Cargando…

Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review

Coronary artery bypass grafting is the gold standard strategy for obtaining complete coronary revascularization in patients with multivessel coronary artery disease. The recent AHA and EACTS guidelines on myocardial revascularization recommend total arterial revascularization, especially in younger...

Descripción completa

Detalles Bibliográficos
Autores principales: Maestri, Francesco, Formica, Francesco, Gallingani, Alan, Gripshi, Florida, Nicolini, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171861/
https://www.ncbi.nlm.nih.gov/pubmed/35546025
http://dx.doi.org/10.23750/abm.v93i2.11370
_version_ 1784721762269790208
author Maestri, Francesco
Formica, Francesco
Gallingani, Alan
Gripshi, Florida
Nicolini, Francesco
author_facet Maestri, Francesco
Formica, Francesco
Gallingani, Alan
Gripshi, Florida
Nicolini, Francesco
author_sort Maestri, Francesco
collection PubMed
description Coronary artery bypass grafting is the gold standard strategy for obtaining complete coronary revascularization in patients with multivessel coronary artery disease. The recent AHA and EACTS guidelines on myocardial revascularization recommend total arterial revascularization, especially in younger patients, whenever possible. However, the use of saphenous vein grafts in association with single or bilateral internal thoracic artery (SITA, BITA) instead of arterial grafts (radial arteries, right gastroepiploic artery and inferior epigastric artery) is widespread. We analyzed literature from the last ten years (January 2010 to December 2020) looking for evidence in favour of the use of a radial artery compared to a saphenous vein in association with BITA. We identified nine studies (4 Systematic Reviews and Meta-analyses and 6 large cohort observational studies with propensity score-matching) that compared arterial with saphenous grafts as third conduit. The main finding of the review is the higher rate of freedom from any cardiac adverse event in the population which reached Total Arterial myocardial Revascularization (TAR). A probable reason for the limited application of TAR as a strategy is the shortage of Randomized Controlled Trials (RCTs). (www.actabiomedica.it)
format Online
Article
Text
id pubmed-9171861
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-91718612022-06-29 Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review Maestri, Francesco Formica, Francesco Gallingani, Alan Gripshi, Florida Nicolini, Francesco Acta Biomed Review Coronary artery bypass grafting is the gold standard strategy for obtaining complete coronary revascularization in patients with multivessel coronary artery disease. The recent AHA and EACTS guidelines on myocardial revascularization recommend total arterial revascularization, especially in younger patients, whenever possible. However, the use of saphenous vein grafts in association with single or bilateral internal thoracic artery (SITA, BITA) instead of arterial grafts (radial arteries, right gastroepiploic artery and inferior epigastric artery) is widespread. We analyzed literature from the last ten years (January 2010 to December 2020) looking for evidence in favour of the use of a radial artery compared to a saphenous vein in association with BITA. We identified nine studies (4 Systematic Reviews and Meta-analyses and 6 large cohort observational studies with propensity score-matching) that compared arterial with saphenous grafts as third conduit. The main finding of the review is the higher rate of freedom from any cardiac adverse event in the population which reached Total Arterial myocardial Revascularization (TAR). A probable reason for the limited application of TAR as a strategy is the shortage of Randomized Controlled Trials (RCTs). (www.actabiomedica.it) Mattioli 1885 2022 2022-05-11 /pmc/articles/PMC9171861/ /pubmed/35546025 http://dx.doi.org/10.23750/abm.v93i2.11370 Text en Copyright: © 2022 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Review
Maestri, Francesco
Formica, Francesco
Gallingani, Alan
Gripshi, Florida
Nicolini, Francesco
Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review
title Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review
title_full Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review
title_fullStr Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review
title_full_unstemmed Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review
title_short Radial Artery Versus Saphenous Vein as Third Conduit in Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: a Ten-Year Literature Review
title_sort radial artery versus saphenous vein as third conduit in coronary artery bypass graft surgery for multivessel coronary artery disease: a ten-year literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171861/
https://www.ncbi.nlm.nih.gov/pubmed/35546025
http://dx.doi.org/10.23750/abm.v93i2.11370
work_keys_str_mv AT maestrifrancesco radialarteryversussaphenousveinasthirdconduitincoronaryarterybypassgraftsurgeryformultivesselcoronaryarterydiseaseatenyearliteraturereview
AT formicafrancesco radialarteryversussaphenousveinasthirdconduitincoronaryarterybypassgraftsurgeryformultivesselcoronaryarterydiseaseatenyearliteraturereview
AT gallinganialan radialarteryversussaphenousveinasthirdconduitincoronaryarterybypassgraftsurgeryformultivesselcoronaryarterydiseaseatenyearliteraturereview
AT gripshiflorida radialarteryversussaphenousveinasthirdconduitincoronaryarterybypassgraftsurgeryformultivesselcoronaryarterydiseaseatenyearliteraturereview
AT nicolinifrancesco radialarteryversussaphenousveinasthirdconduitincoronaryarterybypassgraftsurgeryformultivesselcoronaryarterydiseaseatenyearliteraturereview